Emergent BioSolutions Inc... (EBS)
NYSE: EBS
· Real-Time Price · USD
9.07
0.23 (2.60%)
At close: Aug 18, 2025, 3:59 PM
8.90
-1.92%
Pre-market: Aug 19, 2025, 06:23 AM EDT
2.60% (1D)
| Bid | 8.6 |
| Market Cap | 484.16M |
| Revenue (ttm) | 846.2M |
| Net Income (ttm) | 139.5M |
| EPS (ttm) | 2.62 |
| PE Ratio (ttm) | 3.46 |
| Forward PE | 8.9 |
| Analyst | Buy |
| Ask | 9.2 |
| Volume | 1,144,376 |
| Avg. Volume (20D) | 1,305,285 |
| Open | 8.80 |
| Previous Close | 8.84 |
| Day's Range | 8.80 - 9.38 |
| 52-Week Range | 4.02 - 13.28 |
| Beta | 1.98 |
Analyst Forecast
According to 0 analyst ratings, the average rating for EBS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Emergent BioSolutions Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+36.65%
Emergent BioSolutions shares are trading higher af...
Unlock content with
Pro Subscription
1 week ago
-1.15%
Emergent BioSolutions shares are trading higher after the company reported better-than-expected Q2 financial results.
